Locate EECP® Therapy Treatment Centers

Quick Facts

  • An estimated 16.3 million people in the U.S. suffer from coronary heart disease; it is the No. 1 killer of Americans.

  • This year, 785,000 Americans will have a new coronary attack and about 470,000 will have a recurrent attack.

  • The most common symptom of coronary heart disease is angina, also known as chest pain. 9 million people in this country suffer with this crippling pain.

  • Coronary artery disease can lead to heart failure, a condition that affects more than 5.7 million Americans with over 500,000 new cases diagnosed each year.
Source of Quick Facts: Association (AHA) Heart Disease and Stroke Statistics - 2012 update

Chances are that you or someone you know has been diagnosed with coronary artery disease or heart failure. It's frightening when you consider that these are serious conditions for which there are no cures. The good news is these diseases can be managed, and living a full and enjoyable life with the right treatment and healthy lifestyle is possible. EECP therapy has been used extensively to eliminate or improve angina for many patients, particularly those with congestive heart failure. Many patients have reduced the need for nitroglycerin or eliminated use altogether.

Developed by VasoMedical, Inc., EECP therapy has been tested in multicenter, controlled, clinical studies, with positive medical results and a demonstrated quality of life improvement. Enhancing your life's rhythm is at the heart of EECP therapy. With Medicare coverage, there's one more good reason to ask your doctor if EECP therapy is the treatment for you. EECP treatment centers are located around the world.

©2017 Vaso Corporation